Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Type III secretion system (T3SS), also known as the injectisome, is a specialized protein export apparatus found in many Gram-negative bacteria. It functions as a molecular syringe, enabling these bacteria to inject effector proteins directly from their cytoplasm into the cytoplasm of eukaryotic host cells. This direct translocation bypasses the extracellular environment and is a key mechanism for bacterial virulence and colonization. T3SS is a multi-component nanomachine composed of a basal body, export apparatus, needle filament, sorting platform, and translocation pore. Effector proteins manipulate host cell processes such as actin cytoskeleton rearrangement, cellular trafficking, apoptosis, and immune responses. Because T3SSs are essential for infection progression but absent from humans, they represent attractive targets for antivirulence therapies.
Inhibition of T3SS assembly or function prevents effector protein translocation and reduces bacterial virulence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type III Secretion System (T3SS).